• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,186.87 1.44
( 0.00%)
Global Indices
Nasdaq
52,663.96 134.69
(0.26%)
Dow Jones
7,591.19 26.60
(0.35%)
Hang Seng
66,873.37 -1,878.14
(-2.73%)
Nikkei 225
10,512.27 -17.12
(-0.16%)
Forex
USD-INR
96.14 0.39
(0.40%)
EUR-INR
109.70 0.52
(0.48%)
GBP-INR
128.61 0.54
(0.42%)
JPY-INR
0.59 0.00
(0.41%)

EQUITY - MARKET SCREENER

Texmaco Rail & Engineering Ltd
Industry :  Engineering
BSE Code
ISIN Demat
Book Value()
533326
INE621L01012
57.2690922
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
TEXRAIL
25.47
4819.31
EPS(TTM)
Face Value()
Div & Yield %
4.65
1
0.63
 

oxygenta pharmaceutical ltd
E & E Enterprises reports standalone net loss of Rs 0.10 crore in the March 2026 quarter
May 20,2026
Net Loss of E & E Enterprises reported to Rs 0.10 crore in the quarter ended March 2026 as against net loss of Rs 0.32 crore during the previous quarter ended March 2025. There were no Sales reported in the quarter ended March 2026 as against Rs 0.22 crore during the previous quarter ended March 2025.

For the full year,net profit rose 41.67% to Rs 0.17 crore in the year ended March 2026 as against Rs 0.12 crore during the previous year ended March 2025. There were no Sales reported in the year ended March 2026 as against Rs 0.30 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales00.22 -100 00.30 -100
OPM %0-109.09 -0-116.67 -
PBDT-0.05-0.24 79 0.380.29 31
PBT-0.12-0.24 50 0.240.29 -17
NP-0.10-0.32 69 0.170.12 42